{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:20:24Z","timestamp":1783502424468,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Diabetes Metab Disord"],"DOI":"10.1007\/s40200-026-01999-0","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:25:31Z","timestamp":1783495531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Burden of non-communicable diseases by Socio-demographic Index: a national and subnational analysis in Iran"],"prefix":"10.1007","volume":"25","author":[{"given":"Mostafa","family":"Moghimi Kheirabady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Bagherian Ghotbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Golestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazila","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0105-3801","authenticated-orcid":false,"given":"Sina","family":"Azadnajafabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"1999_CR1","doi-asserted-by":"crossref","unstructured":"Melaku YA, Bassil M, Tayyem RFA, ElObeid T, Zhao L, Manger S et al. The Impact of Unhealthy Lifestyle on the Burden of Non-Communicable Diseases in the State of Qatar: A Systematic Analysis of the Global Burden of Disease Study 2021. Am J Lifestyle Med. 2025:15598276251405214.","DOI":"10.1177\/15598276251405214"},{"issue":"11","key":"1999_CR2","first-page":"e74333","volume":"16","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang X, Wang C, Zhou J. Global, Regional, and National Burden of Cardiovascular Disease, 1990\u20132021: Results From the 2021 Global Burden of Disease Study. Cureus. 2024;16(11):e74333.","journal-title":"Cureus"},{"issue":"1","key":"1999_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13045-024-01640-8","volume":"17","author":"Z Wu","year":"2024","unstructured":"Wu Z, Xia F, Lin R. Global burden of cancer and associated risk factors in 204 countries and territories, 1980\u20132021: a systematic analysis for the GBD 2021. J Hematol Oncol. 2024;17(1):119.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"1999_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pccm.2025.05.005","volume":"3","author":"Z Cao","year":"2025","unstructured":"Cao Z, He L, Luo Y, Tong X, Zhao J, Huang K, et al. Burden of chronic respiratory diseases and their attributable risk factors in 204 countries and territories, 1990\u20132021: Results from the global burden of disease study 2021. Chin Med J Pulm Crit Care Med. 2025;3(2):100\u201310.","journal-title":"Chin Med J Pulm Crit Care Med"},{"key":"1999_CR5","doi-asserted-by":"publisher","first-page":"1596127","DOI":"10.3389\/fendo.2025.1596127","volume":"16","author":"C Pan","year":"2025","unstructured":"Pan C, Cao B, Fang H, Liu Y, Zhang S, Luo W, et al. Global burden of diabetes mellitus 1990\u20132021: epidemiological trends, geospatial disparities, and risk factor dynamics. Front Endocrinol (Lausanne). 2025;16:1596127.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10134","key":"1999_CR6","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/S0140-6736(18)30482-3","volume":"391","author":"LW Niessen","year":"2018","unstructured":"Niessen LW, Mohan D, Akuoku JK, Mirelman AJ, Ahmed S, Koehlmoos TP, et al. Tackling socioeconomic inequalities and non-communicable diseases in low-income and middle-income countries under the Sustainable Development agenda. Lancet. 2018;391(10134):2036\u201346.","journal-title":"Lancet"},{"issue":"2","key":"1999_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40200-020-00709-8","volume":"23","author":"S Azadnajafabad","year":"2021","unstructured":"Azadnajafabad S, Mohammadi E, Aminorroaya A, Fattahi N, Rezaei S, Haghshenas R, et al. Non-communicable diseases\u2019 risk factors in Iran; a review of the present status and action plans. J Diabetes Metab Disord. 2021;23(2):1\u20139.","journal-title":"J Diabetes Metab Disord"},{"key":"1999_CR8","unstructured":"Sustainable Development Goals: United Nations Development Programme. 2024 [Available from: https:\/\/www.undp.org\/sustainable-development-goals"},{"key":"1999_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/ijerph17165788","volume":"17","author":"DS Go","year":"2020","unstructured":"Go DS, Kim YE, Yoon SJ. Subnational Burden of Disease According to the Sociodemographic Index in South Korea. Int J Environ Res Public Health. 2020;17:16.","journal-title":"Int J Environ Res Public Health"},{"issue":"10053","key":"1999_CR10","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/S0140-6736(16)31460-X","volume":"388","author":"HALE Collaborators","year":"2016","unstructured":"GBD 2015 DALYs and HALE Collaborators. GBD 2015 DALYs and, Collaborators HALE. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1603\u201358.","journal-title":"Lancet"},{"key":"1999_CR11","doi-asserted-by":"publisher","first-page":"838027","DOI":"10.3389\/fendo.2022.838027","volume":"13","author":"S Safiri","year":"2022","unstructured":"Safiri S, Karamzad N, Kaufman JS, Bell AW, Nejadghaderi SA, Sullman MJM, et al. Prevalence, Deaths and Disability-Adjusted-Life-Years (DALYs) Due to Type 2 Diabetes and Its Attributable Risk Factors in 204 Countries and Territories, 1990\u20132019: Results From the Global Burden of Disease Study 2019. Front Endocrinol (Lausanne). 2022;13:838027.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1999_CR12","doi-asserted-by":"publisher","first-page":"e072385","DOI":"10.1136\/bmj-2022-072385","volume":"379","author":"J Xie","year":"2022","unstructured":"Xie J, Wang M, Long Z, Ning H, Li J, Cao Y, et al. Global burden of type 2 diabetes in adolescents and young adults, 1990\u20132019: systematic analysis of the Global Burden of Disease Study 2019. BMJ. 2022;379:e072385.","journal-title":"BMJ"},{"issue":"3","key":"1999_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"Global Burden of Disease Cancer Collaboration","year":"2022","unstructured":"Global Burden of Disease Cancer Collaboration. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022;8(3):420\u201344.","journal-title":"JAMA Oncol"},{"key":"1999_CR14","doi-asserted-by":"publisher","first-page":"1501690","DOI":"10.3389\/fendo.2024.1501690","volume":"15","author":"KJ He","year":"2024","unstructured":"He KJ, Wang H, Xu J, Gong G, Liu X, Guan H. Global burden of type 2 diabetes mellitus from 1990 to 2021, with projections of prevalence to 2044: a systematic analysis across SDI levels for the global burden of disease study 2021. Front Endocrinol (Lausanne). 2024;15:1501690.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1999_CR15","doi-asserted-by":"publisher","first-page":"1066804","DOI":"10.3389\/fmed.2023.1066804","volume":"10","author":"X Chen","year":"2023","unstructured":"Chen X, Zhou CW, Fu YY, Li YZ, Chen L, Zhang QW, et al. Global, regional, and national burden of chronic respiratory diseases and associated risk factors, 1990\u20132019: Results from the Global Burden of Disease Study 2019. Front Med (Lausanne). 2023;10:1066804.","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"1999_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/eurjpc\/zwae384","volume":"32","author":"MS Wang","year":"2025","unstructured":"Wang MS, Deng JW, Geng WY, Zheng R, Xu HL, Dong Y, et al. Temporal trend and attributable risk factors of cardiovascular disease burden for adults 55 years and older in 204 countries\/territories from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021. Eur J Prev Cardiol. 2025;32(7):539\u201352.","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"1999_CR17","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/ijc.33114","volume":"147","author":"J Lortet-Tieulent","year":"2020","unstructured":"Lortet-Tieulent J, Georges D, Bray F, Vaccarella S. Profiling global cancer incidence and mortality by socioeconomic development. Int J Cancer. 2020;147(11):3029\u201336.","journal-title":"Int J Cancer"},{"issue":"10184","key":"1999_CR18","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0140-6736(18)33197-0","volume":"393","author":"G Danaei","year":"2019","unstructured":"Danaei G, Farzadfar F, Kelishadi R, Rashidian A, Rouhani OM, Ahmadnia S, et al. Iran in transition. Lancet. 2019;393(10184):1984\u20132005.","journal-title":"Lancet"},{"key":"1999_CR19","unstructured":"Noncommunicable diseases progress monitor 2020: World Health Organization. 2020 [Available from: https:\/\/www.who.int\/publications\/i\/item\/ncd-progress-monitor-2020"},{"issue":"1","key":"1999_CR20","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1186\/s12889-021-12326-y","volume":"21","author":"A Ahmadi","year":"2021","unstructured":"Ahmadi A, Shirani M, Khaledifar A, Hashemzadeh M, Solati K, Kheiri S, et al. Non-communicable diseases in the southwest of Iran: profile and baseline data from the Shahrekord PERSIAN Cohort Study. BMC Public Health. 2021;21(1):2275.","journal-title":"BMC Public Health"},{"issue":"1","key":"1999_CR21","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1186\/s12889-022-13615-w","volume":"22","author":"M Yousefi","year":"2022","unstructured":"Yousefi M, Dastan I, Alinezhad F, Ranjbar M, Hamelmann C, Ostovar A, et al. Prevention and control of non-communicable diseases in iran: the case for Investment. BMC Public Health. 2022;22(1):1248.","journal-title":"BMC Public Health"},{"key":"1999_CR22","unstructured":"WHO Health Financing Team. Health system transformation in the Islamic Republic of Iran: an assessment of key health financing and governance issues. WHO; 2020."},{"key":"1999_CR23","first-page":"151","volume":"35","author":"M Jafari","year":"2021","unstructured":"Jafari M, Ghasemyani S, Khodayari-Zaranq R, Raoofi S. Health Transformation Plan Achievements and Outcomes in Iran (2014\u20132020): A Scoping Review. Med J Islam Repub Iran. 2021;35:151.","journal-title":"Med J Islam Repub Iran"},{"issue":"10335","key":"1999_CR24","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)02751-3","volume":"399","author":"GBD 2019 Iran Collaborators","year":"2022","unstructured":"GBD 2019 Iran Collaborators. Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;399(10335):1625\u201345.","journal-title":"Lancet"},{"issue":"2","key":"1999_CR25","doi-asserted-by":"publisher","first-page":"e0211622","DOI":"10.1371\/journal.pone.0211622","volume":"14","author":"F Khosravi Shadmani","year":"2019","unstructured":"Khosravi Shadmani F, Farzadfar F, Larijani B, Mirzaei M, Haghdoost AA. Trend and projection of mortality rate due to non-communicable diseases in Iran: A modeling study. PLoS ONE. 2019;14(2):e0211622.","journal-title":"PLoS ONE"},{"issue":"1","key":"1999_CR26","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1038\/s41598-020-59668-y","volume":"10","author":"Z Khorrami","year":"2020","unstructured":"Khorrami Z, Rezapour M, Etemad K, Yarahmadi S, Khodakarim S, Mahdavi Hezaveh A, et al. The patterns of Non-communicable disease Multimorbidity in Iran: A Multilevel Analysis. Sci Rep. 2020;10(1):3034.","journal-title":"Sci Rep"},{"issue":"10440","key":"1999_CR27","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"AJ Ferrari","year":"2024","unstructured":"Ferrari AJ, Santomauro DF, Aali A, Abate YH, Abbafati C, Abbastabar H, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years(DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133\u201361.","journal-title":"Lancet"},{"key":"1999_CR28","doi-asserted-by":"crossref","unstructured":"Brauer M, Roth GA, Aravkin AY, Zheng P, Abate KH, Abate YH, et al. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024;403(10440):2162\u2013203.","DOI":"10.1016\/S0140-6736(24)00933-4"},{"key":"1999_CR29","doi-asserted-by":"crossref","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1204\u201322.","DOI":"10.1016\/S0140-6736(20)30925-9"},{"issue":"1","key":"1999_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41598-023-28013-4","volume":"13","author":"A Mtintsilana","year":"2023","unstructured":"Mtintsilana A, Craig A, Mapanga W, Dlamini SN, Norris SA. Association between socio-economic status and non-communicable disease risk in young adults from Kenya, South Africa, and the United Kingdom. Sci Rep. 2023;13(1):728.","journal-title":"Sci Rep"},{"key":"1999_CR31","doi-asserted-by":"crossref","unstructured":"Naghavi M, Ong KL, Aali A, Ababneh HS, Abate YH, Abbafati C, et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024;403(10440):2100\u201332.","DOI":"10.1016\/S0140-6736(24)00367-2"},{"issue":"3","key":"1999_CR32","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1097\/JS9.0000000000002260","volume":"111","author":"J Li","year":"2025","unstructured":"Li J, Pandian V, Davidson PM, Song Y, Chen N, Fong DYT. Burden and attributable risk factors of non-communicable diseases and subtypes in 204 countries and territories, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Int J Surg. 2025;111(3):2385\u201397.","journal-title":"Int J Surg"},{"issue":"1","key":"1999_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13690-024-01454-7","volume":"83","author":"X Li","year":"2025","unstructured":"Li X, Zhao C, Liu M, Zhao W, Pan H, Wang D. Sociodemographic index\u2013age differences in the global prevalence of cardiovascular diseases, 1990\u20132019: a population-based study. Archives Public Health. 2025;83(1):2.","journal-title":"Archives Public Health"},{"issue":"1","key":"1999_CR34","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1186\/s12889-022-14274-7","volume":"22","author":"H Pan","year":"2022","unstructured":"Pan H, Zhao Z, Deng Y, Zheng Z, Huang Y, Huang S, et al. The global, regional, and national early-onset colorectal cancer burden and trends from 1990 to 2019: results from the Global Burden of Disease Study 2019. BMC Public Health. 2022;22(1):1896.","journal-title":"BMC Public Health"},{"issue":"10225","key":"1999_CR35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709\u201333.","journal-title":"Lancet"},{"issue":"7","key":"1999_CR36","doi-asserted-by":"publisher","first-page":"e593","DOI":"10.1016\/S2468-2667(22)00092-5","volume":"7","author":"B Clarsen","year":"2022","unstructured":"Clarsen B, Nylenna M, Klitkou ST, Vollset SE, Baravelli CM, B\u00f8lling AK, et al. Changes in life expectancy and disease burden in Norway, 1990\u20132019: an analysis of the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(7):e593\u2013605.","journal-title":"Lancet Public Health"},{"issue":"5","key":"1999_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00394-025-03715-9","volume":"64","author":"S Sengupta","year":"2025","unstructured":"Sengupta S, Thomsen ST, Davydova A, Redondo HG, Jakobsen LS, Pires SM. Burden of disease of seven dietary risk factors in population groups with similar lifestyle patterns in Denmark. Eur J Nutr. 2025;64(5):201.","journal-title":"Eur J Nutr"},{"issue":"4","key":"1999_CR38","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/1740774516643498","volume":"13","author":"S Huang","year":"2016","unstructured":"Huang S, Fiero MH, Bell ML. Generalized estimating equations in cluster randomized trials with a small number of clusters: Review of practice and simulation study. Clin Trials. 2016;13(4):445\u20139.","journal-title":"Clin Trials"},{"issue":"1","key":"1999_CR39","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12889-021-10429-0","volume":"21","author":"M Amini","year":"2021","unstructured":"Amini M, Zayeri F, Salehi M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017. BMC Public Health. 2021;21(1):401.","journal-title":"BMC Public Health"},{"issue":"1","key":"1999_CR40","doi-asserted-by":"publisher","first-page":"21908","DOI":"10.1038\/s41598-023-49249-0","volume":"13","author":"M Balooch Hasankhani","year":"2023","unstructured":"Balooch Hasankhani M, Mirzaei H, Karamoozian A. Global trend analysis of diabetes mellitus incidence, mortality, and mortality-to-incidence ratio from 1990 to 2019. Sci Rep. 2023;13(1):21908.","journal-title":"Sci Rep"},{"key":"1999_CR41","doi-asserted-by":"publisher","first-page":"e073043","DOI":"10.1136\/bmj-2022-073043","volume":"381","author":"W Yan","year":"2023","unstructured":"Yan W, Qin C, Tao L, Guo X, Liu Q, Du M, et al. Association between inequalities in human resources for health and all cause and cause specific mortality in 172 countries and territories, 1990\u20132019: observational study. BMJ. 2023;381:e073043.","journal-title":"BMJ"},{"issue":"7","key":"1999_CR42","first-page":"419","volume":"20","author":"M Moradi-Lakeh","year":"2017","unstructured":"Moradi-Lakeh M, Sepanlou SG, Karimi SM, Khalili N, Djalalinia S, Karimkhani C, et al. Trend of Socio-Demographic Index and Mortality Estimates in Iran and its Neighbors, 1990\u20132015; Findings of the Global Burden of Diseases 2015 Study. Arch Iran Med. 2017;20(7):419\u201328.","journal-title":"Arch Iran Med"},{"issue":"1","key":"1999_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12939-020-01372-4","volume":"20","author":"L Doshmangir","year":"2021","unstructured":"Doshmangir L, Bazyar M, Rashidian A, Gordeev VS. Iran health insurance system in transition: equity concerns and steps to achieve universal health coverage. Int J Equity Health. 2021;20(1):37.","journal-title":"Int J Equity Health"},{"key":"1999_CR44","unstructured":"Roudi F, Azadi P, Mesgaran M. Iran\u2019s Population Dynamics and Demographic Window of Opportunity2017."},{"key":"1999_CR45","unstructured":"Economic and Social Commission for Asia and the Pacific. ESCAP population data sheet 2025 [Available from: https:\/\/www.unescap.org\/kp\/2025\/escap-population-data-sheet-2025"},{"issue":"10","key":"1999_CR46","doi-asserted-by":"publisher","first-page":"e76881","DOI":"10.1371\/journal.pone.0076881","volume":"8","author":"R Khajehkazemi","year":"2013","unstructured":"Khajehkazemi R, Sadeghirad B, Karamouzian M, Fallah MS, Mehrolhassani MH, Dehnavieh R, et al. The projection of burden of disease in Islamic Republic of Iran to 2025. PLoS ONE. 2013;8(10):e76881.","journal-title":"PLoS ONE"},{"issue":"3","key":"1999_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.gheart.2018.09.511","volume":"13","author":"H Thomas","year":"2018","unstructured":"Thomas H, Diamond J, Vieco A, Chaudhuri S, Shinnar E, Cromer S, et al. Global Atlas of Cardiovascular Disease 2000\u20132016: The Path to Prevention and Control. Glob Heart. 2018;13(3):143\u201363.","journal-title":"Glob Heart"},{"issue":"1","key":"1999_CR48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12939-016-0478-6","volume":"15","author":"B Palafox","year":"2016","unstructured":"Palafox B, McKee M, Balabanova D, AlHabib KF, Avezum AJ, Bahonar A, et al. Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries. Int J Equity Health. 2016;15(1):199.","journal-title":"Int J Equity Health"},{"key":"1999_CR49","doi-asserted-by":"publisher","first-page":"1605502","DOI":"10.3389\/ijph.2023.1605502","volume":"68","author":"J Bai","year":"2023","unstructured":"Bai J, Cui J, Shi F, Yu C. Global Epidemiological Patterns in the Burden of Main Non-Communicable Diseases, 1990\u20132019: Relationships With Socio-Demographic Index. Int J Public Health. 2023;68:1605502.","journal-title":"Int J Public Health"},{"issue":"2","key":"1999_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5603\/ARM.2017.0016","volume":"85","author":"S Sahni","year":"2017","unstructured":"Sahni S, Talwar A, Khanijo S, Talwar A. Socioeconomic status and its relationship to chronic respiratory disease. Adv Respir Med. 2017;85(2):97\u2013108.","journal-title":"Adv Respir Med"},{"issue":"1","key":"1999_CR51","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12931-022-02187-3","volume":"23","author":"A Fallahzadeh","year":"2022","unstructured":"Fallahzadeh A, Sharifnejad Tehrani Y, Sheikhy A, Ghamari SH, Mohammadi E, Saeedi Moghaddam S, et al. The burden of chronic respiratory disease and attributable risk factors in North Africa and Middle East: findings from global burden of disease study (GBD) 2019. Respir Res. 2022;23(1):268.","journal-title":"Respir Res"},{"issue":"1","key":"1999_CR52","doi-asserted-by":"publisher","first-page":"10272","DOI":"10.1038\/s41598-023-37299-3","volume":"13","author":"M Abbasi-Kangevari","year":"2023","unstructured":"Abbasi-Kangevari M, Ghanbari A, Fattahi N, Malekpour MR, Masinaei M, Ahmadi N, et al. Tobacco consumption patterns among Iranian adults: a national and sub-national update from the STEPS survey 2021. Sci Rep. 2023;13(1):10272.","journal-title":"Sci Rep"},{"key":"1999_CR53","doi-asserted-by":"publisher","first-page":"571062","DOI":"10.3389\/fpubh.2020.571062","volume":"8","author":"MR Sohrabi","year":"2020","unstructured":"Sohrabi MR, Abbasi-Kangevari M, Kolahi AA. Current Tobacco Smoking Prevalence Among Iranian Population: A Closer Look at the STEPS Surveys. Front Public Health. 2020;8:571062.","journal-title":"Front Public Health"},{"issue":"1","key":"1999_CR54","doi-asserted-by":"publisher","first-page":"14386","DOI":"10.1038\/s41598-022-18613-x","volume":"12","author":"S Faridi","year":"2022","unstructured":"Faridi S, Bayat R, Cohen AJ, Sharafkhani E, Brook JR, Niazi S, et al. Health burden and economic loss attributable to ambient PM(2.5) in Iran based on the ground and satellite data. Sci Rep. 2022;12(1):14386.","journal-title":"Sci Rep"},{"issue":"4","key":"1999_CR55","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","volume":"3","author":"C Fitzmaurice","year":"2017","unstructured":"Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3(4):524\u201348.","journal-title":"JAMA Oncol"},{"issue":"8","key":"1999_CR56","doi-asserted-by":"publisher","first-page":"e0330993","DOI":"10.1371\/journal.pone.0330993","volume":"20","author":"SM Mousavi","year":"2025","unstructured":"Mousavi SM, Younesian S, Katebian S, Golestani A, Khanmohammadi S, Khosravi S, et al. Temporal trend in the national and sub-national burden of cancers attributable to risk factors in Iran from 1990 to 2021: Findings from the global burden of disease study 2021. PLoS ONE. 2025;20(8):e0330993.","journal-title":"PLoS ONE"},{"issue":"2","key":"1999_CR57","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1053\/j.gastro.2019.10.029","volume":"158","author":"JM Carethers","year":"2020","unstructured":"Carethers JM, Doubeni CA. Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies. Gastroenterology. 2020;158(2):354\u201367.","journal-title":"Gastroenterology"},{"issue":"5","key":"1999_CR58","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/eurpub\/ckw070","volume":"26","author":"A Lundqvist","year":"2016","unstructured":"Lundqvist A, Andersson E, Ahlberg I, Nilbert M, Gerdtham U. Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis. Eur J Public Health. 2016;26(5):804\u201313.","journal-title":"Eur J Public Health"},{"key":"1999_CR59","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.vhri.2023.05.005","volume":"37","author":"T Hofmarcher","year":"2023","unstructured":"Hofmarcher T, Manzano Garc\u00eda A, Wilking N, Lindgren P. The Disease Burden and Economic Burden of Cancer in 9 Countries in the Middle East and Africa. Value Health Reg Issues. 2023;37:81\u20137.","journal-title":"Value Health Reg Issues"},{"issue":"1a","key":"1999_CR60","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1079\/PHN2001287","volume":"5","author":"H Ghassemi","year":"2002","unstructured":"Ghassemi H, Harrison G, Mohammad K. An accelerated nutrition transition in Iran. Public Health Nutr. 2002;5(1a):149\u201355.","journal-title":"Public Health Nutr"},{"key":"1999_CR61","doi-asserted-by":"publisher","first-page":"1149719","DOI":"10.3389\/fpubh.2023.1149719","volume":"11","author":"S Moradi","year":"2023","unstructured":"Moradi S, Parsaei A, Saeedi Moghaddam S, Aryannejad A, Azadnajafabad S, Rezaei N, et al. Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019. Front Public Health. 2023;11:1149719.","journal-title":"Front Public Health"},{"issue":"2","key":"1999_CR62","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s40200-022-01108-x","volume":"21","author":"SF Mousavi","year":"2022","unstructured":"Mousavi SF, Peimani M, Moghaddam SS, Tabatabaei-Malazy O, Ghasemi E, Shobeiri P, et al. National and subnational survey on diabetes burden and quality of care index in Iran: a systematic analysis of the global burden of disease study 1990\u20132019. J Diabetes Metab Disord. 2022;21(2):1599\u2013608.","journal-title":"J Diabetes Metab Disord"},{"issue":"2","key":"1999_CR63","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s40200-020-00713-y","volume":"23","author":"N Fattahi","year":"2024","unstructured":"Fattahi N, Azadnajafabad S, Mohammadi E, Aminorroaya A, Rezaei S, Ghasemi E, et al. Geographical, gender and age inequalities in non-communicable diseases both at national and provincial levels in Iran. J Diabetes Metab Disord. 2024;23(2):1525\u201331.","journal-title":"J Diabetes Metab Disord"},{"issue":"3","key":"1999_CR64","doi-asserted-by":"publisher","first-page":"e064540","DOI":"10.1136\/bmjopen-2022-064540","volume":"13","author":"X Feng","year":"2023","unstructured":"Feng X, Hou N, Chen Z, Liu J, Li X, Sun X, et al. Secular trends of epidemiologic patterns of chronic kidney disease over three decades: an updated analysis of the Global Burden of Disease Study 2019. BMJ Open. 2023;13(3):e064540.","journal-title":"BMJ Open"},{"issue":"10440","key":"1999_CR65","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GBD 2021 Risk Factors Collaborators","year":"2024","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2162\u2013203.","journal-title":"Lancet"},{"issue":"10518","key":"1999_CR66","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","volume":"406","author":"PB Mark","year":"2025","unstructured":"Mark PB, Stafford LK, Grams ME, Aalruz H, Abd ElHafeez S, Abdelgalil AA, et al. Global, regional, and national burden of chronic kidney disease in adults, 1990\u20132023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025;406(10518):2461\u201382.","journal-title":"Lancet"},{"issue":"10397","key":"1999_CR67","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2023","unstructured":"Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203\u201334.","journal-title":"Lancet"}],"container-title":["Journal of Diabetes & Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40200-026-01999-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40200-026-01999-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40200-026-01999-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:05:33Z","timestamp":1783501533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40200-026-01999-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1999"],"URL":"https:\/\/doi.org\/10.1007\/s40200-026-01999-0","relation":{},"ISSN":["2251-6581"],"issn-type":[{"value":"2251-6581","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a secondary analysis of publicly available, previously collected, and deidentified data from the Global Burden of Disease Study 2021. Therefore, participant consent is not applicable. This study received approval from the institutional review board of the Endocrinology and Metabolism Research Institute at Tehran University of Medical Sciences (IR.TUMS.EMRI.REC.1401.160).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}